THERAPEUTIC CUT-OFF OF INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

被引：0
|
作者：
Nagore, D. [1 ]
Ruiz del Agua, A. [1 ]
Pascual, J. [1 ]
Llinares-Tello, F. [2 ]
Herreros, B. [3 ]
Martinez, A. [1 ]
Martin, S. [1 ,4 ]
Navarro, R. [5 ]
机构：
[1] Progenika, R&D, Derio, Spain
[2] Hosp Marina Baixa, Clin Anal, Villajoyosa, Spain
[3] Hosp Marina Baixa, Digest Dis, Villajoyosa, Spain
[4] Univ Basque Country UPV EHU, Sch Med & Dent, Zabalduz Scholarship Programme, Dept Physiol, Leioa, Spain
[5] Univ Basque Country UPV EHU, Sch Med & Dent, Dept Physiol, Leioa, Spain
来源：
GUT | 2015年 / 64卷
关键词：
D O I：
10.1136/gutjnl-2015-309861.202
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PTU-087
引用
收藏
页码：A99 / A99
页数：1
相关论文
共 50 条
  • [1] Therapeutic Cut- Off of Infliximab in Patients With Inflammatory Bowel Diseases
    Nagore, Daniel
    del Agua, Ainhoa Ruiz
    Pascual, Javier
    Llinares-Tello, Francisca
    Herreros, Belen
    Martinez, Antonio
    GASTROENTEROLOGY, 2015, 148 (04) : S860 - S860
  • [2] Determination of infliximab cut-off concentrations predicting presence or absence of antibodies towards infliximab (ATI) in chronic inflammatory diseases
    Chasseuil, E.
    Mulleman, D.
    Aubourg, A.
    Lecomte, T.
    Paintaud, G.
    Ternant, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 42 - 42
  • [3] Infliximab desensitization in patients with Inflammatory Bowel Diseases: a safe therapeutic alternative
    Hammoudi, N.
    Hassid, D.
    Bonnet, J.
    Minh, M. L. Tran
    Baudry, C.
    Chedouba, L.
    Vauthier, A.
    Gornet, J. M.
    Allez, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 643 - 643
  • [4] Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative
    Hammoudi, Nassim
    Hassid, Deborah
    Bonnet, Joelle
    Tran Minh, My-Linh
    Baudry, Clotilde
    Vauthier, Anne
    Chedouba, Leila
    Houze, Pascal
    Lourenco, Nelson
    Aparicio, Thomas
    Gornet, Jean-Marc
    Allez, Matthieu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (05) : 553 - 560
  • [5] Cut-off value of fecal calprotectin in pediatric patients with inflammatory bowel disease
    Veres, G.
    Giczi, D.
    Cseh, A.
    Szabo, D.
    Mueller, K. E.
    Csepregi, N.
    Arato, A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S411 - S411
  • [6] Distinct cut-off values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease
    Park, Sang Hyoung
    Al Bawardy, Badr
    Aniwan, Satimai
    Kane, Sunanda V.
    Prabhu, Nayantara Coelho
    Papadakis, Konstantinos A.
    Kisiel, John B.
    Bruining, David H.
    Faubion, William A.
    Raffals, Laura E.
    Pardi, Darrell S.
    Tremaine, William J.
    Khanna, Sahil
    Loftus, Edward V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 63 - 63
  • [7] New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases
    Nemoz, Benjamin
    Ternant, David
    Bailly, Sebastien
    Gautier-Veyret, Elodie
    Jourdil, Jean-Francois
    Bonaz, Bruno
    Stanke-Labesque, Francoise
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (04) : 722 - 728
  • [8] Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases
    Papamichael, Konstantinos
    Clarke, William T.
    Vande Casteele, Niels
    Germansky, Katharine A.
    Feuerstein, Joseph D.
    Melmed, Gil Y.
    Siegel, Corey A.
    Irving, Peter M.
    Cheifetz, Adam S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (04) : 839 - +
  • [9] Correspondence: fecal calprotectin and cut-off levels in inflammatory bowel disease
    Kristensen, Vendel
    Moum, Bjorn
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 1183 - 1184
  • [10] Subcutaneous infliximab cut-off points in a large cohort of Spanish patients with inflammatory bowel disease and factors associated with long-term outcomes
    Iborra, M.
    Caballol, B.
    Garrido, A.
    Huguet, J. M.
    Mesonero, F.
    Ponferrada, A.
    Arias-Garcia, L.
    Bosca-Watts, M. M.
    Fernandez-Prada, S. J.
    Brunet-Mas, E.
    Gutierrez-Casbas, A.
    Ordas, I.
    Ruiz, L.
    Garcia de la Filia, I.
    Escobar Ortiz, J.
    Sicilia, B.
    Ricart, E.
    Nos, P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1013 - I1014
12345